Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 7883

  • Filters activated: Cancer. Clear all to show 28149 items.
1.

Supramolecular functionalization of carbon nano-onions with hyaluronic acid-phospholipid conjugates for selective targeting of cancer cells.

d'Amora M, Camisasca A, Boarino A, Giordani S, Arpicco S.

Colloids Surf B Biointerfaces. 2020 Jan 8;188:110779. doi: 10.1016/j.colsurfb.2020.110779. [Epub ahead of print]

PMID:
31955017
2.

Ligand-installed anti-VEGF genomic nanocarriers for effective gene therapy of primary and metastatic tumors.

Zhang H, Liu J, Chen Q, Mi P.

J Control Release. 2020 Jan 16. pii: S0168-3659(20)30045-6. doi: 10.1016/j.jconrel.2020.01.026. [Epub ahead of print]

PMID:
31954731
3.

Spreading Pattern and Tissue Response to Hyaluronic Acid Gel Injections in the Subcutis: Ultrasound Videos, Ultrasound Measurements, and Histology.

Vandeputte J, Leemans G, Dhaene K, Forsyth R, Vanslembrouck J, Hatem F, Micheels P.

Aesthet Surg J. 2020 Jan 17. pii: sjaa007. doi: 10.1093/asj/sjaa007. [Epub ahead of print]

PMID:
31950138
4.

Hyaluronic acid and vitamin E polyethylene glycol succinate functionalized gold-core silica shell nanorods for cancer targeted photothermal therapy.

Jacinto TA, Rodrigues CF, Moreira AF, Miguel SP, Costa EC, Ferreira P, Correia IJ.

Colloids Surf B Biointerfaces. 2020 Jan 9;188:110778. doi: 10.1016/j.colsurfb.2020.110778. [Epub ahead of print]

PMID:
31945632
5.

Construction and application of targeted drug delivery system based on hyaluronic acid and heparin functionalised carbon dots.

Duan Q, Ma L, Zhang B, Zhang Y, Li X, Wang T, Zhang W, Li Y, Sang S.

Colloids Surf B Biointerfaces. 2019 Dec 31;188:110768. doi: 10.1016/j.colsurfb.2019.110768. [Epub ahead of print]

PMID:
31945629
6.

Remodeling extracellular matrix based on functional covalent organic framework to enhance tumor photodynamic therapy.

Wang SB, Chen ZX, Gao F, Zhang C, Zou MZ, Ye JJ, Zeng X, Zhang XZ.

Biomaterials. 2020 Jan 9;234:119772. doi: 10.1016/j.biomaterials.2020.119772. [Epub ahead of print]

PMID:
31945618
7.

Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer.

He H, Liu L, Liang R, Zhou H, Pan H, Zhang S, Cai L.

Acta Biomater. 2020 Jan 13. pii: S1742-7061(20)30013-1. doi: 10.1016/j.actbio.2020.01.012. [Epub ahead of print]

PMID:
31945508
8.

Distinguishing Specific CXCL12 Isoforms on Their Angiogenesis and Vascular Permeability Promoting Properties.

Chang CW, Seibel AJ, Avendano A, Cortes-Medina MG, Song JW.

Adv Healthc Mater. 2020 Jan 15:e1901399. doi: 10.1002/adhm.201901399. [Epub ahead of print]

PMID:
31944591
9.

Oral lichen planus and lichenoid lesions: what's new?

Schmidt-Westhausen AM.

Quintessence Int. 2020;51(2):156-161. doi: 10.3290/j.qi.a43868.

PMID:
31942576
10.

Particle diffusion in extracellular hydrogels.

Burla F, Sentjabrskaja T, Pletikapic G, van Beugen J, Koenderink GH.

Soft Matter. 2020 Jan 15. doi: 10.1039/c9sm01837a. [Epub ahead of print]

PMID:
31939987
11.

The role of CD44 in Tumor-initiating Cells of Salivary Gland Pleomorphic Adenoma: more than a surface biomarker.

Shen S, Lu H, Liu L, Wang Y, Zhang C, Yang W, Xu W.

Oral Dis. 2020 Jan 11. doi: 10.1111/odi.13279. [Epub ahead of print]

PMID:
31926047
12.

Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in vivo.

Men W, Zhu P, Dong S, Liu W, Zhou K, Bai Y, Liu X, Gong S, Zhang S.

Drug Deliv. 2020 Dec;27(1):180-190. doi: 10.1080/10717544.2019.1709922.

PMID:
31924103
13.

Facile synthesis and functionalization of color-tunable Ln3+-doped KGdF4 nanoparticles on a microfluidic platform.

Ma J, Yi C, Li CW.

Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110381. doi: 10.1016/j.msec.2019.110381. Epub 2019 Nov 1.

PMID:
31924035
14.

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer.

Li K, Zhan W, Chen Y, Jha RK, Chen X.

Front Pharmacol. 2019 Dec 18;10:1436. doi: 10.3389/fphar.2019.01436. eCollection 2019.

15.

Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.

Wang H, Zhang F, Wen H, Shi W, Huang Q, Huang Y, Xie J, Li P, Chen J, Qin L, Zhou Y.

J Nanobiotechnology. 2020 Jan 9;18(1):8. doi: 10.1186/s12951-019-0562-3.

16.

A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics.

Leite DM, Zvar Baskovic B, Civita P, Neto C, Gumbleton M, Pilkington GJ.

FASEB J. 2020 Jan;34(1):1710-1727. doi: 10.1096/fj.201901858RR. Epub 2019 Dec 5.

PMID:
31914660
17.

Host-guest fabrication of dual-responsive hyaluronic acid/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy.

Lu J, Luo B, Chen Z, Yuan Y, Kuang Y, Wan L, Yao L, Chen X, Jiang B, Liu J, Li C.

Int J Biol Macromol. 2020 Jan 3;146:363-373. doi: 10.1016/j.ijbiomac.2019.12.265. [Epub ahead of print]

PMID:
31911174
18.
19.

Self-Renewal Capability of Hepatocytic Parental Progenitor Cells Derived From Adult Rat Liver Is Maintained Long Term When Cultured on Laminin 111 in Serum-Free Medium.

Kino J, Ichinohe N, Ishii M, Suzuki H, Mizuguchi T, Tanimizu N, Mitaka T.

Hepatol Commun. 2019 Nov 2;4(1):21-37. doi: 10.1002/hep4.1442. eCollection 2020 Jan.

20.

Enhanced cytotoxicity of a redox-sensitive hyaluronic acid-based nanomedicine toward different oncocytes via various internalization mechanisms.

Du Y, Wang S, Zhang T, He D, Tu J, Shen Y.

Drug Deliv. 2020 Dec;27(1):128-136. doi: 10.1080/10717544.2019.1709919.

PMID:
31894722

Supplemental Content

Loading ...
Support Center